Biochemical Marker to Predict the Recurrence of Atrial Fibrillation After Surgical Maze Procedure
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00542659|
Recruitment Status : Completed
First Posted : October 11, 2007
Last Update Posted : July 25, 2011
The role of plasma NT-proBNP, hsCRP, TIMP-1(Tissue inhibitors of MetalloProteinase-1),TGF-b, MMP-3(Matrix MetalloProteinase-3), and pro-MMP-1 in predicting the recurrence of AF after surgical Maze procedure.
The association of expression of CTGF, TGF-b, BNP, ANP, collagen-1, and collagen-3 in LA with the recurrence of AF after surgical Maze procedure.
|Condition or disease|
|Study Type :||Observational|
|Estimated Enrollment :||86 participants|
|Official Title:||Plasma ANP and NT-pro-BNP, Atrial Anatomical Change May Determine the Outcome of Maze Operation|
|Study Start Date :||February 2005|
|Actual Primary Completion Date :||December 2007|
|Actual Study Completion Date :||February 2008|
- AF recurrence [ Time Frame: year ]
Biospecimen Retention: Samples Without DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00542659
|Korea, Republic of|
|Samsung Medical Center|
|Seoul, Korea, Republic of, 135-710|
|Principal Investigator:||Young Keun On, MD||Samsung Medical Center|